{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T06:47:12Z","timestamp":1769237232405,"version":"3.49.0"},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"55","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,7]]},"DOI":"10.18632\/oncotarget.20750","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T20:36:03Z","timestamp":1504902963000},"page":"93729-93740","source":"Crossref","is-referenced-by-count":28,"title":["Hyaluronic acid enhances cell migration and invasion via the YAP1\/TAZ-RHAMM axis in malignant pleural mesothelioma"],"prefix":"10.18632","volume":"8","author":[{"given":"Wataru","family":"Shigeeda","sequence":"first","affiliation":[{"name":"Department of Tumor Biology, Institute of Biomedical Science, Iwate Medical University, Iwate, Japan"},{"name":"Department of Thoracic Surgery, School of Medicine, Iwate Medical University, Iwate, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Shibazaki","sequence":"additional","affiliation":[{"name":"Department of Tumor Biology, Institute of Biomedical Science, Iwate Medical University, Iwate, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Yasuhira","sequence":"additional","affiliation":[{"name":"Department of Tumor Biology, Institute of Biomedical Science, Iwate Medical University, Iwate, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Iwate Medical University, Iwate, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Tanita","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, School of Medicine, Iwate Medical University, Iwate, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Tumor Biology, Institute of Biomedical Science, Iwate Medical University, Iwate, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Sekido","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihaya","family":"Maesawa","sequence":"additional","affiliation":[{"name":"Department of Tumor Biology, Institute of Biomedical Science, Iwate Medical University, Iwate, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,9,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Lake","year":"2005","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00508-016-1080-z","article-title":"Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG)","volume":"128","author":"Klepetko","year":"2016","journal-title":"Wien Klin Wochenschr"},{"key":"3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jtho.2016.04.028","article-title":"Consensus Report of the 2015 Weinman International Conference on Mesothelioma","volume":"11","author":"Gavett","year":"2016","journal-title":"J Thorac Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","article-title":"Mesothelioma epidemiology, carcinogenesis, and pathogenesis","volume":"9","author":"Carbone","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jjco\/hyv039","article-title":"A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index","volume":"45","author":"Fukuhara","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/0284186X.2012.709948","article-title":"Treatment and survival analyses of malignant mesothelioma in Japan","volume":"52","author":"Kishimoto","year":"2013","journal-title":"Acta Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","article-title":"High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas","volume":"92","author":"Testa","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/0008-5472.CAN-10-2164","article-title":"LATS2 is a tumor suppressor gene of malignant mesothelioma","volume":"71","author":"Sekido","year":"2011","journal-title":"Cancer Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.devcel.2008.01.006","article-title":"The TEAD\/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control","volume":"14","author":"Jiang","year":"2008","journal-title":"Dev Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.devcel.2010.06.015","article-title":"The Merlin\/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals","volume":"19","author":"Pan","year":"2010","journal-title":"Dev Cell"},{"key":"11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/ncb1993","article-title":"YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway","volume":"11","author":"Haber","year":"2009","journal-title":"Nat Cell Biol"},{"key":"12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrm3416","article-title":"Transduction of mechanical and cytoskeletal cues by YAP and TAZ","volume":"13","author":"Piccolo","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1073\/pnas.1319190110","article-title":"Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility","volume":"111","author":"Zheng","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1038\/onc.2010.339","article-title":"YAP dysregulation by phosphorylation or DeltaNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets","volume":"29","author":"Van Waes","year":"2010","journal-title":"Oncogene"},{"key":"15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.1843810","article-title":"A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)","volume":"24","author":"Guan","year":"2010","journal-title":"Genes Dev"},{"key":"16","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/MCB.01874-07","article-title":"TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway","volume":"28","author":"Guan","year":"2008","journal-title":"Mol Cell Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"37159","DOI":"10.1074\/jbc.M110.152942","article-title":"The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase","volume":"285","author":"Lei","year":"2010","journal-title":"J Biol Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/ijc.29073","article-title":"Hippo-YAP signaling pathway: A new paradigm for cancer therapy","volume":"137","author":"Qin","year":"2015","journal-title":"Int J Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the Roots of Cancer","volume":"29","author":"Piccolo","year":"2016","journal-title":"Cancer Cell"},{"key":"20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.canlet.2016.10.020","article-title":"Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP\/CD44 growth stimulatory axis","volume":"385","author":"Sekido","year":"2017","journal-title":"Cancer Lett"},{"key":"21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","article-title":"The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells","volume":"147","author":"Basso","year":"2011","journal-title":"Cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1101\/gad.1903310","article-title":"The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation","volume":"24","author":"Guan","year":"2010","journal-title":"Genes Dev"},{"key":"23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-13-1854","article-title":"Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes\/YAP axis","volume":"20","author":"Dumont","year":"2014","journal-title":"Clin Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1158\/0008-5472.CAN-13-2712","article-title":"YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway","volume":"74","author":"Yang","year":"2014","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1038\/onc.2012.5","article-title":"YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes","volume":"31","author":"Sekido","year":"2012","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1378\/chest.94.5.1037","article-title":"Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma","volume":"94","author":"Klockars","year":"1988","journal-title":"Chest"},{"key":"27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1084\/jem.175.1.257","article-title":"Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody","volume":"175","author":"Kincade","year":"1992","journal-title":"J Exp Med"},{"key":"28","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1074\/jbc.R100038200","article-title":"Signaling properties of hyaluronan receptors","volume":"277","author":"Bourguignon","year":"2002","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"publisher","first-page":"39957","DOI":"10.18632\/oncotarget.9554","article-title":"Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma","volume":"7","author":"Du","year":"2016","journal-title":"Oncotarget"},{"key":"30","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.3892\/ol.2015.3773","article-title":"Upregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival","volume":"10","author":"He","year":"2015","journal-title":"Oncol Lett"},{"key":"31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/onc.2013.528","article-title":"LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade","volume":"34","author":"Sekido","year":"2015","journal-title":"Oncogene"},{"key":"32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Piccolo","year":"2011","journal-title":"Nature"},{"key":"33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ceb.2008.10.001","article-title":"The Hippo-YAP pathway: new connections between regulation of organ size and cancer","volume":"20","author":"Guan","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic control of YAP and TAZ by the mevalonate pathway","volume":"16","author":"Del Sal","year":"2014","journal-title":"Nat Cell Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/ncb3216","article-title":"Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth","volume":"17","author":"Piccolo","year":"2015","journal-title":"Nat Cell Biol"},{"key":"36","first-page":"567","article-title":"The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression","volume":"4","author":"Turley","year":"1998","journal-title":"Clin Cancer Res"},{"key":"37","first-page":"201","article-title":"Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer","volume":"6","author":"Ghatak","year":"2015","journal-title":"Front Immunol"},{"key":"38","doi-asserted-by":"crossref","first-page":"26461","DOI":"10.1074\/jbc.M110.121491","article-title":"RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1\/ERK1\/2 activity","volume":"285","author":"Turley","year":"2010","journal-title":"J Biol Chem"},{"key":"39","doi-asserted-by":"crossref","first-page":"16667","DOI":"10.1074\/jbc.M702078200","article-title":"The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells","volume":"282","author":"Turley","year":"2007","journal-title":"J Biol Chem"},{"key":"40","doi-asserted-by":"crossref","first-page":"11342","DOI":"10.1074\/jbc.273.18.11342","article-title":"The hyaluronan receptor RHAMM regulates extracellular-regulated kinase","volume":"273","author":"Turley","year":"1998","journal-title":"J Biol Chem"},{"key":"41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.biopha.2016.04.008","article-title":"LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression","volume":"82","author":"Yang","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Werb","year":"2010","journal-title":"Cell"},{"key":"43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1101\/gad.262816.115","article-title":"A YAP\/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis","volume":"29","author":"Guan","year":"2015","journal-title":"Genes Dev"},{"key":"44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0625.2007.00638.x","article-title":"Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4","volume":"17","author":"Simon","year":"2008","journal-title":"Exp Dermatol"},{"key":"45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-016-2213-5","article-title":"Hyaluronic acid in digestive cancers","volume":"143","author":"Geng","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bjc.2014.332","article-title":"Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis","volume":"111","author":"Sleeman","year":"2014","journal-title":"Br J Cancer"},{"key":"47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients","volume":"97","author":"Hida","year":"2006","journal-title":"Cancer Sci"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:03:13Z","timestamp":1589205793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,8]]},"references-count":47,"journal-issue":{"issue":"55","published-print":{"date-parts":[[2017,11,7]]}},"alternative-id":["20750","29212185"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20750","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,8]]}}}